Friedreich's ataxia (FRDA) is a progressive neurodegenerative disease characterized by ataxia, variously associating heart disease, diabetes mellitus and/or glucose intolerance. It results from intronic expansion of GAA triplet repeats at the FXN locus. Homozygous expansions cause silencing of the FXN gene and subsequent decreased expression of the encoded mitochondrial frataxin. Detailed analyses in fibroblasts and neuronal tissues from FRDA patients have revealed profound cytoskeleton anomalies. So far, however, the molecular mechanism underlying these cytoskeleton defects remains unknown. We show here that gene silencing spreads in cis over the PIP5K1B gene in cells from FRDA patients (circulating lymphocytes and primary fibroblasts), correlating with expanded GAA repeat size. PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase b type I (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P 2 ]. Accordingly, loss of pip5k1b function in FRDA cells was accompanied by decreased PI(4,5)P 2 levels and was shown instrumental for destabilization of the actin network and delayed cell spreading. Knockdown of PIP5K1B in control fibroblasts using shRNA reproduced abnormal actin cytoskeleton remodeling, whereas over-expression of PIP5K1B, but not FXN, suppressed this phenotype in FRDA cells. In addition to provide new insights into the consequences of the FXN gene expansion, these findings raise the question whether PIP5K1B silencing may contribute to the variable manifestation of this complex disease.
INTRODUCTION
Friedreich's ataxia (FRDA) is the prevalent autosomal recessive ataxia in the Caucasian population with an incidence of approximately 1 out of 50 000. With a striking variability, onset typically occurs around puberty and the disorder is stepwise progressive presenting limb and gait ataxia. The phenotypic spectrum includes progressive spinocerebellar neurodegeneration, sensory neuropathy and deep sensory impairment with signs of pyramidal tract involvement, whereas non-neurological manifestations such as hypertrophic cardiomyopathy and increased incidence of diabetes are additional heterogeneous features (1, 2) . In 98% of cases, this complex phenotype is caused by homozygous expansions of unstable GAA triplet repeats in the first intron of the FXN gene on chromosome 9q21, decreasing levels of the encoded mitochondrial frataxin below a pathogenic threshold (3) . The rare remaining atypical cases are compound heterozygotes with an expanded GAA repeat on one and a different deleterious mutation in the second FXN allele.
Several lines of evidence now point to epigenetic mechanisms as the main cause of FXN silencing in FRDA (4) . The * To whom correspondence should be addressed. Tel: +33 140031989; Fax: +33 140031995; Email: aurelien.bayot@inserm.fr # The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com concept first arose from the observation that relatively short GAA expansions of 200 repeats are sufficient to confer variegated gene silencing of a linked mouse transgene marker, in a manner analogous to position-effect variegation (5) . Then, a number of epigenetic studies conducted in patient cells (4, 6, 7) and mouse models (8, 9) demonstrated the ability of GAA expansions to generate transcriptionally inactive chromatin at the FXN locus.
Data from patient endomyocardial biopsies (10) as well as from frataxin-depleted yeasts (10, 11) and mouse models (12) have stated that the disease results primarily from impairment of iron -sulfur cluster (ISC)-containing proteins (ISPs), thus supplying compelling arguments for intra-mitochondrial function of frataxin in the biogenesis of ISCs. Various mitochondrial dysfunctions, hypersensitivity to oxidative insults and defective handling of mitochondrial iron have also been reported (13 -15) .
Intriguingly, patient fibroblasts, despite normal ISC biogenesis, display profound cytoskeleton abnormalities with defective organization of actin stress fibers and decreased fluorescence of F-actin staining (16) . This echoes the neuronal cytoskeleton defects noticed in the spinal cord of patients, consisting in a significant rise in the dynamic pool of b-tubulin due to abnormal microtubular polymerization, as well as irregular distribution of phosphorylated neurofilaments (17) . These anomalies are not readily reconciled with the known frataxin function in ISC biogenesis, thus pointing to a frataxin-independent mechanism. As triplet expansions in noncoding regions of genes have been shown to mediate cis-effects (18, 19) , impaired expression of the PIP5K1B gene located nearby the FXN locus and functionally linked to actin cytoskeleton dynamics (20) might possibly account for these abnormalities. To directly test this hypothesis, we carried out a gene expression analysis coupled with a functional genetic approach in primary fibroblasts and circulating lymphocytes from control and FRDA individuals.
RESULTS
Concurrent silencing of FXN and PIP5K1B genes in fibroblasts from FRDA patients correlates with GAA repeat size
The PIP5K1B gene is located 26 kb from the 5 ′ end of the FXN gene, whereas two other genes, PRKACG and TJP2, flank the FXN locus, respectively, at the 5 ′ end and the 3 ′ end of the gene (Fig. 1A) . In primary fibroblasts from five FRDA patients (FRDA1 -FRDA5) carrying variable GAA repeat expansions (Fig. 1B and Supplementary Material,  Table S1 ), we quantified by qRT -PCR the steady-state mRNA levels of FXN and of the neighboring PIP5K1B and TJP2 genes, transcribed in the same orientation. As expected, the FXN transcript was strongly diminished in all patient fibroblasts (Fig. 1C) . Strikingly, we observed a parallel decrease, although less pronounced, especially for patient FRDA4, in the PIP5K1B but not TJP2 mRNAs, whereas both FXN and PIP5K1B silencing correlated with GAA expansion size (Fig. 1C , compare with Fig. 1B for correlation with GAA repeat size). The PRKACG transcript, transcribed in the opposite direction, was undetectable in our experimental conditions, despite the use of three different primer couples, indicating very low gene expression in cultured fibroblasts. As predicted from the impaired gene expression, both frataxin and pip5k1b protein levels were found reduced in patient fibroblasts ( Fig. 1D and Supplementary Material, Fig. S1 ).
In contrast, the PIP5K1A gene, which maps to the unrelated chromosome 1q22 and encodes PIP5K a type 1 isoform, was normally expressed in FRDA fibroblasts (Supplementary Material, Fig. S2 ), excluding a general transcriptional repressive effect on this class of enzymes.
Depletion of frataxin and pip5k1b in FRDA patient's blood cells Fig. 2A) , where the protein acts. In contrast, FRDA fibroblasts sustained a dramatic loss of pip5k1b at the PM ( Fig. 2A) , consistent with decreased expression of PIP5K1B ( Fig. 1C and D) . This was also evident from co-staining of pip5k1b and vinculin, a focal adhesion component involved in cytoskeleton/PM connection, which revealed a concomitant absence of the two proteins at the sites of adhesion (Supplementary Material, Fig. S3A ) and a size reduction of focal contacts in patient fibroblasts (Supplementary Material, Fig. S3B ). This was not correlated with decreased content of the vinculin protein (Supplementary Material, Fig. S3C ). Quantification of intracellular protein distribution indicated that PM targeting of pip5k1b was almost completely abolished in FRDA cells (Fig. 2B) . Accordingly, cellular concentrations of PI(4,5)P 2 were found decreased in FRDA fibroblasts (Fig. 2C ) and circulating lymphocytes ( Table 1) . As phosphoinositides (PI) are readily inter-convertible (21) , this may be a consequence of both a decrease in PI(4,5)P 2 production and increased turnover rate.
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Pip5k1b depletion in FRDA cells is associated with cytoskeleton anomalies
Destabilization of the actin network Impairment of actin stress fibers is an unexplained hallmark of FRDA fibroblasts (16, 22) . Besides typical function in signal transduction at the cell surface, PI(4,5)P 2 is an essential signaling phospholipid for remodeling of the actin network (23, 24) , consistent with pip5k1b being a key regulatory factor of actin cytoskeleton dynamics (20, 25) . Studying filamentous actin (F-actin), we found a dramatic drop in F-actin fluorescence in sub-confluent FRDA fibroblasts ( 
Delayed cell spreading
Actin cytoskeleton remodeling is known to generate the physical force driving cell motility (27) . We, therefore, investigated whether destabilization of the actin network in FRDA fibroblasts might influence the ability of freshly lifted cells to adhere and spread on fibronectin-coated surfaces (28) . In spreading control fibroblasts, pip5k1b was recruited to membrane ruffles at the leading edge of membranous protrusions, whereas part of the protein was also found in the perinuclear region ( Fig. 3B and Supplementary Material, Fig. S6A ). In contrast, in spreading FRDA cells, residual pip5k1b was strictly restricted to the perinuclear region, correlating with a failure of lamellipodia, the actin cytoskeletal projections, to properly reorganize on the mobile edge of the cells (Fig. 3B and Supplementary Material, Fig. S6A ). Severely reduced PI(4,5)P 2 levels were also observed at the leading edge of spreading patient fibroblasts ( Fig. 3C and Supplementary Material, Fig. S6B ). Co-immunostaining of vinculin/F-actin provided further evidence that impaired synthesis of PI(4,5)P 2 at membrane protrusions prevents the migration cycle to proceed efficiently (29) (Supplementary Material, Fig. S6C ). Accordingly, FRDA fibroblasts displayed a clear delay in cell spreading, as evidenced by an accumulation of earlyspreading intermediates 45 min after seeding (Fig. 3D ).
Genetic and molecular characterization of the actin network destabilization
Down-regulation of PIP5K1B in control fibroblasts
The evidence of pip5k1b depletion as a possible cause of the cytoskeleton alterations in FRDA prompted us to examine the functional effect of PIP5K1B down-regulation in normal Fig. S8A ). When FRDA patient fibroblasts were transfected with the expression construct, cells overexpressing HApip5k1b exhibited increased PI(4,5)P 2 levels ( Fig. 5A and Supplementary Material, Fig. S9A ). Strikingly, all patient fibroblasts overexpressing HA-pip5k1b displayed a noticeable increase in stress fiber formation ( Fig. 5B and Supplementary Material, Fig. S9B ). Despite the variability in HA-pip5k1b overexpression, quantification showed recovery of F-actin fluorescence to reach almost normal levels (Fig. 5B , graphic panel). Notably, a complete rescue of the actin network was nevertheless only observed within those cells which recovered normal levels of PI(4,5)P 2 ( Fig. 5C and Supplementary Material, Fig. S9C ).
FXN overexpression in FRDA fibroblasts
In order to rule out the involvement of frataxin in the cytoskeleton anomalies of FRDA fibroblasts, we overexpressed frataxin-6HIS in patient cells. The fusion frataxin-6HIS was efficiently expressed and targeted to mitochondria in HeLa cells and fibroblasts (Supplementary Material, Fig. S8B and C). As shown in Figure 5D , frataxin-6HIS overexpression failed to restore stress fibers in patient cells (see also Supplementary Material, Fig. S9D ). We conclude that the actin network destabilization of FRDA fibroblasts is independent of the frataxin cellular content and can be fully ascribed to PIP5K1B silencing.
DISCUSSION
The present data demonstrate concurrent silencing of FXN and PIP5K1B genes in fibroblasts and lymphocytes from FRDA patients carrying homozygous GAA expansions. Significantly, PIP5K1B was for a while considered as a candidate gene for FRDA, mainly based on linkage analyses (30, 31) . The hypothesis was later abandoned in the face of massive evidence connecting FXN to the disease. Our results, however, demonstrate PIP5K1B silencing in cells of homozygous FRDA patients that essentially reflects the size of the smallest GAA expansion. Considering the tendency of expanded GAA repeats to generate local transcriptionally inactive chromatin (4 -7), and the ability of non-coding triplet expansions to mediate cis-effects (18, 19) , our data are consistent with a transcriptional repression model, whereby gene silencing spreads over the PIP5K1B neighboring gene. As distinct mechanisms may be consistent with effects of GAA triplet repeats on transcription of genes over distances of hundreds of kilobases (32, 33) , it will be of particular interest to investigate the molecular bases for this long-range gene-silencing effect.
Functional studies clearly identify pip5k1b depletion as the primary lesion responsible for cytoskeleton anomalies in FRDA fibroblasts, thus providing the molecular mechanism for the disorganization of actin stress fibers and the decreased fluorescence of F-actin staining (16, 22) . Deficient pip5k1b signalization in patient fibroblasts is further emphasized by incorrect assembly of the migration machinery and subsequent delayed cell spreading (29) . Interestingly, fibroblasts from patients with Lowe syndrome, a rare X-linked disorder resulting from mutations in a PI(4,5)P 2 5-phosphatase, were shown to similarly display actin cytoskeleton defects as well as impaired cell migration and spreading (34, 35) . The loss of focal contact integrity that we observed in FRDA fibroblasts is consistent with the role of pip5k1b as a fundamental regulatory factor of focal adhesion dynamics (36, 37) , supporting a model by which abnormal elongation of actin stress fibers at focal adhesion sites destabilizes the actin network (38, 39) (Supplementary Material, Fig. S10 ). It appears obvious that pip5k1b-dependent PI(4,5)P 2 pools are specifically affected in this defective cascade, likely resulting in misregulation of a number of cytoskeletal proteins (23, 24) , as we observed in the case of vinculin at focal contacts of FRDA fibroblasts. Of note, this may account for the increased glutathionylation of cytoskeletal proteins in fibroblasts and neuronal tissues from FRDA individuals (16, 17) . In the spinal cord of patients, the significant rise in the dynamic pool of b-tubulin associated with abnormal microtubular polymerization as well as irregular distribution of phosphorylated neurofilaments is also consistent with aberrant PI(4,5)P 2 signaling-mediated misregulation of cytoskeletal proteins, thus pointing to a generalized defect in FRDA (17) .
As genetic alterations affecting gene expression at a distance, while keeping transcriptional unit intact, are currently emerging as contributing factors in several human genetic diseases (40, 41) , it is tempting to suggest that PIP5K1B participates to the variable manifestation of FRDA when partially silenced in combination with FXN. Frataxin insufficiency has been shown to undermine the activity of several ISPs in affected tissues of patients (mainly the heart) and in a number of animal and cell models (10) (11) (12) . These ISPs have central functions in key metabolic pathways, e.g. respiratory chain activity and control of cellular iron homeostasis, and their malfunction can exert various effects on mitochondria and cell physiology, ultimately causing diseases (42) . In addition, possibly as a result of poor mitochondrial iron handling, frataxin insufficiency has been associated with hypersensitivity to oxidative insults (13, 15) . On the other hand, pip5k1b insufficiency, which decreases the synthesis of the signaling PI(4,5)P 2 molecule, can perturb numerous important cell functions including membrane trafficking and various processes dependent on a properly organized cytoskeleton (20, 23, 43, 44) . Decreased PI(4,5)P 2 levels found in circulating lymphocytes from FRDA patients are without any doubt related to Pip5k1b depletion in these cells. In agreement, an altered distribution of phospholipid classes has been noticed early in FRDA erythrocyte membranes (45, 46) . More recently, gene expression profiling in patient lymphocytes has highlighted differential expression of a set of genes linked to phospholipid metabolism and PM organization, most of them encode secreted or integral PM proteins (47) . Although the role of frataxin in altered lipid metabolism and lipid peroxidation has been recently addressed using Drosophila and mouse models of FRDA (48, 49) 
blood samples are more easily envisioned to result from PIP5K1B than from FXN silencing, as these cells preserve ISPdependent activities despite their low frataxin levels (50) . In keeping with this, decreased phosphatidylethanolamine and phosphatidylserine levels have been observed in the brain of patients (51), which was further associated with abnormal activity of membrane phospholipid synthetic enzymes (52) . All these changes may be envisioned as an adaptative response subsequent to pip5k1b depletion, raising the possibility to use the pip5k1b protein as well as its product PI(4,5)P 2 as novel 
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Although the three isoforms of pip5k1 (designated as a, b and g) all generate the same phospholipid product, they show variable tissue specificity and different developmental pattern of expression in the brain (53) , and they appear to localize within different compartments of the cell (20, 25) . Knockout mice studies have suggested a role in the developed nervous system for pip5k1b (53) , which may include functions in neurite outgrowth and remodeling (37, 54, 55) , possibly through the effects of a specific PI(4,5)P 2 pool on actin cytoskeleton dynamics (56) . It is interesting to note that PIP5K1B is highly expressed in the brain and testis and, to a lesser extent, in the heart and lung (53) , thus partially overlapping with FXN tissue expression (3, 12) . Whereas it appears likely that PIP5K1 isoforms have overlapping but not identical functions (20) , implicating a complex functional interplay, it should be noted that impaired PIP5K1 signaling may be consistent with various aspects of FRDA, and at least some correlations emanating from studies in mice can be made at present (57 -59) . Thus, PI(4,5)P 2 is known to play an essential role in synaptic vesicle trafficking, and neurons of pip5k1g 2/2 mice display impaired synaptic transmission associated with endocytic/exocytic defects (57) . To date, only mutation of PIP5K1C encoding the g isoform has been associated with disease in human (60) . The phenotype, which is lethal during the neonatal period, is characterized by multiple joint contractures and may result from aberrant PI(4,5)P 2 signalingmediated defective synaptic vesicle trafficking, providing a plausible cause for neuronal malfunction (60) . Finally, the new perspective provided by the present study makes it of interest to investigate the different clinical presentation reported in the rare heterozygous FRDA patients (61, 62) . In keeping with this, a reduced impact of PIP5K1B silencing resulting from a non-expanded allele is predicted and could account for the observed atypical disease presentation in such cases. Although the potential implication of PIP5K1B in FRDA pathogenesis requires further investigation, ideally in the neuronal and cardiac tissues from patients, our data shed new light on the consequences of the FXN gene expansion in patient cells and might provide unexpected responses to some of the unanswered questions raised in FRDA (63) .
MATERIALS AND METHODS

Additional information is provided in the Supplementary
Material.
Patient's samples and cell culture
Skin and blood samples were obtained from five FRDA patients and five anonymous healthy individuals, all of European ancestry. Informed consent was obtained from patients and/or family members according to protocols approved by the Robert Debré Hospital ethical committee (Paris, France). All FRDA patients were diagnosed by identification of homozygous GAA repeat expansions at the FXN locus (IGBMC, diagnostic center, Strasbourg, France) and their main clinical features are detailed in Supplementary Material, Table S1 . Primary fibroblasts of early passages were derived from skin biopsies and were maintained at similar passages (maximum 13 passages) all along the experiments in DMEM containing 4.5 g/l glucose, 2 mM glutamine (as GlutaMAX TM ), 10% fetal bovine serum (Sigma), 100 U/ml penicillin and 100 mg/ml streptomycin (all from Life Technologies). Cells were incubated at 378C in a humidified atmosphere containing 5% CO 2 . HeLa cells were grown in the same conditions. Determination of GAA repeat length GAA repeats at the FXN locus were amplified using the primers GAA-104F and GAA-629R as described previously (64) .
Analysis of gene and protein expression
Gene expression was measured by qRT -PCR. Total RNAs were extracted from cell pellets (RNeasy Plus Kit, Qiagen) and mRNAs were purified (Oligotex mRNA Kit, Qiagen) according to the manufacturer's instructions. Reverse transcription was performed using 165 ng of mRNAs (iScript cDNA Synthesis Kit, Bio-Rad), and qRT -PCR was conducted using the iQ SYBR Green Supermix (Bio-Rad) with a two-step procedure (988C denaturation, 10 s, 608C annealing and elongation, 30 s for 40 cycles with a 3 min initial denaturation and a 5 s final extension at 658C). Analyses were performed with a CFX96 Real-Time PCR Detection System (Bio-Rad). Each sample was amplified in triplicate and results represent at least three independent experiments. All qRT -PCR signals were normalized to HPRT and results were calculated using the 2-DDCt method. Primer sequences are listed in Supplementary Material, Table S2 . For western blot analysis, total cell lysates were prepared using the RIPA buffer [50 mM Tris -HCl, pH 8.5, 150 mM NaCl, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS] supplemented with a protease inhibitor cocktail (Roche), whereas mitochondria-enriched fractions were isolated as previously described (65) . Proteins were analyzed by western blotting using specific antibodies. Analysis of protein expression in peripheral blood mononuclear cells (PBMCs) was performed by flow cytometry. Freshly isolated PBMCs were fixed, permeabilized and saturated and were processed for immunolabeling. After washing, cells were analyzed on a Navios instrument using the CxP analysis software (Beckman -Coulter). Files were gated according to SSC-FSC characteristics for lymphocyte analysis (Supplementary Material, Fig. S11A) Fig. S11B) . A minimum of 20 000 events were acquired in the lymphocyte gate.
Immunofluorescence and phalloidin staining
Cells grown on glass coverslips were fixed, permeabilized, saturated and subsequently incubated with specific primary and secondary antibodies. For F-actin staining, 2.8 U/ml Alexa Fluor 555-Phalloidin (Life Technologies) was used, 30 min in 1% BSA at 258C, followed by an extensive wash procedure.
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Cell spreading assay
Freshly trypsinized fibroblasts were lifted with 20 mM EDTA in PBS for 1 min, harvested (300 g, 5 min at 258C) and resuspended in complete culture medium. Cell suspensions were then added over fibronectin-coated coverslips (5 mg/cm 2 ) and allowed to spread for 45 min. After spreading, coverslips were gently rinsed with PBS and immediately processed for immunofluorescence analysis. Cell areas were traced and measured using the ImageJ 1.410 software (NIH).
Functional genetic studies
Functional implications of PIP5K1B in the actin cytoskeleton anomalies were first analyzed by down-regulating the gene in control cells. Three different specific shRNA sequences (sh1, sh2, sh3) were cloned into the appropriate silencing vector (pSilencer 2.1-U6 Hygro plasmid; Ambion, Life Technologies) and transfected in control cells using electroporation (Neon Transfection System, Life Technologies). Control experiments were also performed in parallel with the corresponding scrambled constructs (scrbl1, scrbl2, scrbl3). The sequences of sh/scrbRNA are listed in Supplementary Material, Table S3 . On the other hand, genes of interest (HA-PIP5K1B and FXN-6HIS) were overexpressed in patient fibroblasts by transfecting the corresponding expression vectors (pcDNA3.1+, Life Technologies) using electroporation. The functional effects of the shRNA constructs or the expression vectors on the actin cytoskeleton were analyzed 48 h post-transfection by phalloidin staining.
Statistical analysis
Statistical analysis was performed using Student's t-test by considering two independent groups [control (C) and patient (FRDA) groups]. Results are expressed as means + SEM, and P , 0.05 was considered significant.
